litlas
Log inCreate account

Patrick A. Baeuerle

Active 1985–2025

167
Papers
63,672
Citations
124
h-index
163
i10-index

Citations

Citations per year for Patrick A. Baeuerle1979: 1 citations1982: 1 citations1985: 1 citations1986: 2 citations1987: 21 citations1988: 26 citations1989: 89 citations1990: 161 citations1991: 317 citations1992: 562 citations1993: 775 citations1994: 671 citations1995: 947 citations1996: 1,004 citations1997: 1,133 citations1998: 1,373 citations1999: 1,720 citations2000: 1,328 citations2001: 1,068 citations2002: 1,000 citations2003: 780 citations2004: 698 citations2005: 578 citations2006: 590 citations2007: 519 citations2008: 406 citations2009: 510 citations2010: 451 citations2011: 391 citations2012: 475 citations2013: 454 citations2014: 432 citations2015: 372 citations2016: 361 citations2017: 386 citations2018: 335 citations2019: 868 citations2020: 950 citations2021: 918 citations2022: 676 citations2023: 444 citations2024: 672 citations2025: 343 citations2026: 10 citations1980–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,920 citing papers, 36.6% of this breakdownGermany: 1,717 citing papers, 9.1% of this breakdownChina: 1,262 citing papers, 6.7% of this breakdownUnited Kingdom: 1,015 citing papers, 5.4% of this breakdownJapan: 833 citing papers, 4.4% of this breakdownItaly: 721 citing papers, 3.8% of this breakdownFrance: 668 citing papers, 3.5% of this breakdownCanada: 527 citing papers, 2.8% of this breakdownSouth Korea: 460 citing papers, 2.4% of this breakdownSpain: 402 citing papers, 2.1% of this breakdownAustralia: 366 citing papers, 1.9% of this breakdownSwitzerland: 336 citing papers, 1.8% of this breakdown
0%36.6%Other 19.5%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology41.5%
  • Medicine36%
  • Immunology and Microbiology10.7%
  • Neuroscience4.8%
  • Agricultural and Biological Sciences1.9%
  • Nursing1.9%
  • Other3.2%

Topics

  • NF-κB Signaling Pathways7%
  • Immune Response and Inflammation4.4%
  • CAR-T cell therapy research2.8%
  • Monoclonal and Polyclonal Antibodies Research1.8%
  • Cytokine Signaling Pathways and Interactions1.8%
  • Immune Cell Function and Interaction1.7%
  • Other80.5%

Coauthors

All papers

Open in search
  1. Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?

    Authors: Olivier Gires, Min Pan, Henrik Schinke, Martin Canis, Patrick A. Baeuerle - Cancer and Metastasis Reviews 2020 cited by 359

  2. Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

    Authors: Ralf C. Bargou, Eugen Leo, Gerhard Zugmaier, Matthias Klinger, Mariele Goebeler, Stefan Knop, Richard Noppeney, Andreas Viardot, Georg Heß, Martin Schüler, Hermann Einsele, Christian Brandl, Andreas Wolf, Petra Kirchinger, Petra Klappers, Margit Schmidt, Gert Riethmüller, Carsten Reinhardt, Patrick A. Baeuerle, Peter Kufer - Science 2008 cited by 1,083

  3. Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

    Authors: Patrick A. Baeuerle, Jian Ding, Ekta Patel, Niko Thorausch, Holly M. Horton, Jessica J. Gierut, Irene Scarfò, Rashmi Choudhary, Olga Kiner, Janani Krishnamurthy, Bonnie Le, Anna Morath, G. Christian Baldeviano, Justin Quinn, Patrick Tavares, Qi Wei, Solly Weiler, Marcela V. Maus, Daniel R. Getts, Wolfgang W. Schamel, Robert Hofmeister - Nature Communications 2019 cited by 203

  4. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.

    Authors: Ralf Schreck, P. Rieber, Patrick A. Baeuerle - The EMBO Journal 1991 cited by 3,818

  5. Blinatumomab: A historical perspective

    Authors: Dirk Nagorsen, Peter Kufer, Patrick A. Baeuerle, Ralf C. Bargou - Pharmacology & Therapeutics 2012 cited by 359

  6. Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

    Authors: Maria-Elisabeth Goebeler, Stefan Knop, Andreas Viardot, Peter Kufer, Max S. Topp, Hermann Einsele, Richard Noppeney, Georg Heß, С. Каллерт, Andréas Mackensen, Kathrin Rupertus, Lothar Kanz, M. Libicher, Dirk Nagorsen, Gerhard Zugmaier, Matthias Klinger, Andreas Wolf, B Dorsch, Beate D. Quednau, Margit Schmidt, J. Scheele, Patrick A. Baeuerle, Eugen Leo, Ralf C. Bargou - Journal of Clinical Oncology 2016 cited by 421

  7. T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities

    Authors: Patrick A. Baeuerle, Holger Wesche - Current Opinion in Oncology 2022 cited by 69

  8. Function and Activation of NF-kappaB in the Immune System

    Authors: Patrick A. Baeuerle, Thomas Henkel - Annual Review of Immunology 1994 cited by 4,712

  9. Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells

    Authors: Sonja Offner, Robert Hofmeister, Andrea Romaniuk, Peter Kufer, Patrick A. Baeuerle - Molecular Immunology 2005 cited by 365

  10. Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

    Authors: Max S. Topp, Peter Kufer, Nicola Gökbuget, Mariele Goebeler, Matthias Klinger, Svenja Neumann, Heinz-A. Horst, Thorsten Raff, Andreas Viardot, Mathias Schmid, Matthias Stelljes, Markus Schaich, Evelyn Degenhard, R Köhne-Volland, Monika Brüggemann, Oliver G. Ottmann, Heike Pfeifer, Thomas Burmeister, Dirk Nagorsen, Margit Schmidt, Ralf Lutterbuese, Carsten Reinhardt, Patrick A. Baeuerle, Michael Kneba, Hermann Einsele, Gert Riethmüller, Dieter Hoelzer, Gerhard Zugmaier, Ralf C. Bargou - Journal of Clinical Oncology 2011 cited by 913

  11. Bispecific T-Cell Engaging Antibodies for Cancer Therapy

    Authors: Patrick A. Baeuerle, Carsten Reinhardt - Cancer Research 2009 cited by 592

  12. NF-κB: Ten Years After

    Authors: Patrick A. Baeuerle, David Baltimore - Cell 1996 cited by 3,015

  13. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease

    Authors: Barbara Kaltschmidt, Martin Uherek, Benedikt Volk, Patrick A. Baeuerle, Christian Kaltschmidt - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 620

  14. Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody

    Authors: Torsten Dreier, Grit Lorenczewski, Christian Brandl, Patrick Hoffmann, Uwe Syring, Frank Hanakam, Peter Kufer, Gert Riethmüller, Ralf C. Bargou, Patrick A. Baeuerle - International Journal of Cancer 2002 cited by 354

  15. Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

    Authors: Patrick Hoffmann, Robert Hofmeister, Klaus Brischwein, Christian Brandl, Sandrine Crommer, Ralf C. Bargou, Christian Itin, Nadja Prang, Patrick A. Baeuerle - International Journal of Cancer 2005 cited by 344

  16. TriTACs, a Novel Class of T-Cell–Engaging Protein Constructs Designed for the Treatment of Solid Tumors

    Authors: Richard J. Austin, Bryan D. Lemon, Wade H. Aaron, Manasi Barath, Patricia Culp, Robert B. DuBridge, Luke Evnin, Adrie Jones, Anand Panchal, Purbasa Patnaik, Vanitha Ramakrishnan, Sony Sotelo Rocha, Pui Seto, Kenneth G. Sexton, Kathryn L. Strobel, Russell Wall, Stephen Yu, Timothy Z. Yu, Che‐Leung Law, Patrick A. Baeuerle, Holger Wesche - Molecular Cancer Therapeutics 2020 cited by 64

  17. CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330

    Authors: Christina Krupka, Peter Kufer, Roman Kischel, Gerhard Zugmaier, Jan Bögeholz, Thomas Köhnke, Felix S. Lichtenegger, Stephanie Schneider, Klaus H. Metzeler, Michael Fiegl, Karsten Spiekermann, Patrick A. Baeuerle, Wolfgang Hiddemann, Gert Riethmüller, Marion Subklewe - Blood 2013 cited by 207

  18. Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa

    Authors: Gerhard Rogler, Korbinian Brand, Daniela Vogl, Sharon Page, Robert Hofmeister, Tilo Andus, Ruth Knuechel, Patrick A. Baeuerle, Jürgen Schölmerich, Volker Groß - Gastroenterology 1998 cited by 708

  19. EpCAM (CD326) finding its role in cancer

    Authors: Patrick A. Baeuerle, Olivier Gires - British Journal of Cancer 2007 cited by 529

  20. Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen

    Authors: Claudia Bluemel, Susanne Hausmann, Petra Fluhr, Mirnalini Sriskandarajah, William B. Stallcup, Patrick A. Baeuerle, Peter Kufer - Cancer Immunology Immunotherapy 2010 cited by 206

  21. Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing

    Authors: Sandra L. Ross, Marika Sherman, Patricia McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson - PLoS ONE 2017 cited by 112

  22. Nuclear signalling by tumour-associated antigen EpCAM

    Authors: Dorothea Maetzel, Sabine Denzel, Brigitte Mack, Martin Canis, Philip Went, Michael Benk, C. Kieu, Peer Papior, Patrick A. Baeuerle, Markus Münz, Olivier Gires - Nature Cell Biology 2009 cited by 727

  23. Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors

    Authors: Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, Alexander Steinle, Jennifer S. Michaelson, Patrick A. Baeuerle - mAbs 2023 cited by 28

  24. Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia

    Authors: Matthias Friedrich, Anja Henn, Tobias Raum, Monika Bajtus, Katja Matthes, Larissa Hendrich, Joachim Wahl, Patrick Hoffmann, Roman Kischel, Majk Kvesic, Jerry W. Slootstra, Patrick A. Baeuerle, Peter Kufer, Benno Rattel - Molecular Cancer Therapeutics 2014 cited by 136